Hemcheck Sweden AB has received a follow-up order from its UK distributor, CLS. The order concerns instruments for diagnostic use and bgs-Tests and is of smaller economic value.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1435 SEK | -6.82% | +20.08% | -39.71% |
1st Jan change | Capi. | |
---|---|---|
-39.71% | 4.25M | |
-5.47% | 12.27B | |
-3.06% | 7.99B | |
+5.98% | 5.69B | |
+26.16% | 5.42B | |
-10.38% | 4.13B | |
-59.63% | 2.7B | |
+9.56% | 2.6B | |
-4.26% | 2.38B | |
+21.00% | 2.1B |
- Stock Market
- Equities
- BIOVIT Stock
- News Bio Vitos Pharma AB
- Hemcheck Sweden AB Receives Follow-Up Order from CLS